Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Comment by Atomekon Dec 01, 2016 10:24am

169 Views

Post# 25539769

RE:RE:Top 20 TSX Filers Past 7 Days Issuers with Net Buying

Latest 6 months of SEDI filings for PLI by transaction date, descending	?
Amended Filing

					As of 11:59pm ET November 30th, 2016
Filing Date	Transaction Date	Insider Name	Ownership Type	Securities	Nature of transaction	Volume or Value	Price
Nov 30/16	Nov 29/16	Thomvest Asset Management Inc.	Indirect Ownership	Common Shares	10 - Acquisition in the public market	2,499,800	$2.40
Nov 30/16	Nov 29/16	Clulow, Kurt Stefan Victor	Control or Direction	Common Shares	10 - Acquisition in the public market	2,499,800	$2.40
Nov 30/16	Nov 29/16	Hakim, Raymond Manuel	Direct Ownership	Common Shares	10 - Acquisition in the public market	25,000	$1.81 USD
Nov 30/16	Nov 29/16	Hakim, Raymond Manuel	Direct Ownership	Common Shares	10 - Acquisition in the public market	5,000	$1.79 USD
Nov 25/16	Nov 25/16	Mnard, Louise	Direct Ownership	Common Shares	10 - Acquisition in the public market	10,000	$2.47
Nov 24/16	Nov 24/16	Laurin, Pierre	Indirect Ownership	Common Shares	10 - Acquisition in the public market	21,600	$2.45
Nov 24/16	Nov 23/16	Laurin, Pierre	Indirect Ownership	Common Shares	10 - Acquisition in the public market	28,400	$2.48
Nov 25/16	Nov 22/16	Moran, John Edward	Direct Ownership	Common Shares	57 - Exercise of rights	27,579	$1.71
Nov 25/16	Nov 22/16	Moran, John Edward	Direct Ownership	Units d'actions restreintes / Restricted Share Units	57 - Exercise of rights	-27,579	$1.71
Nov 25/16	Nov 22/16	Booth, Jonathan	Direct Ownership	Common Shares	57 - Exercise of rights	10,000	$1.71